{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:36:33Z","timestamp":1794105393800,"version":"4.8.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.biopha.2022.112981","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T13:55:23Z","timestamp":1650635723000},"page":"112981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review"],"prefix":"10.1016","volume":"150","author":[{"given":"Gabriele","family":"Gallo Afflitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"Scuteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacinto","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Nucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112981_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2022.112981_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107835","article-title":"The genetics of angle closure glaucoma","volume":"189","author":"Wang","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IJG.0000000000001120","article-title":"Cigarette smoking on severity of primary angle closure glaucoma in malay patients","volume":"28","author":"Niven","year":"2019","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.biopha.2022.112981_bib4","article-title":"Cholesterol and glaucoma: a systematic review and meta-analysis","author":"Posch-Pertl","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.112981_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ceo.13336","article-title":"Neuroprotection in glaucoma: recent advances and clinical translation","volume":"47","author":"Guymer","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib7","doi-asserted-by":"crossref","first-page":"17078","DOI":"10.3390\/molecules191117078","article-title":"Endocannabinoids, related compounds and their metabolic routes","volume":"19","author":"Fezza","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.112981_bib8","series-title":"Mosaic of Autoimmunity: The Novel Factors of Autoimmune Diseases","first-page":"417","article-title":"Cannabinoids in autoimmune and rheumatic diseases","author":"Navarini","year":"2019"},{"key":"10.1016\/j.biopha.2022.112981_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9124036","article-title":"CannabinEYEds: the endocannabinoid system as a regulator of the ocular surface nociception, inflammatory response, neovascularization and wound healing","volume":"9","author":"Aiello","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.112981_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jbcpp-2015-0065","article-title":"Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease","volume":"27","author":"Cairns","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib11","doi-asserted-by":"crossref","first-page":"9364091","DOI":"10.1155\/2016\/9364091","article-title":"The endocannabinoid system as a therapeutic target in glaucoma","volume":"2016","author":"Cairns","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2022.112981_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0079-6123(08)01131-X","article-title":"Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection","volume":"173","author":"Nucci","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.biopha.2022.112981_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biopha.2022.112981_bib14","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1258\/la.2010.009117","article-title":"Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed","volume":"44","author":"Hooijmans","year":"2010","journal-title":"Lab Anim."},{"key":"10.1016\/j.biopha.2022.112981_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01438-8","article-title":"Cannabinoid CB1 receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues","volume":"431","author":"Stamer","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1167\/iovs.05-0729","article-title":"Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility","volume":"47","author":"Njie","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib17","doi-asserted-by":"crossref","first-page":"3127658","DOI":"10.1155\/2016\/3127658","article-title":"A comparative analysis of the endocannabinoid system in the retina of mice, tree shrews, and monkeys","volume":"2016","author":"Bouskila","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2022.112981_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuroscience.2011.11.041","article-title":"Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys","volume":"202","author":"Bouskila","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2022.112981_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0952523800173079","article-title":"Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings","volume":"17","author":"Yazulla","year":"2000","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cne.22534","article-title":"Cannabinoid receptor type 1 expression during postnatal development of the rat retina","volume":"519","author":"Zabouri","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2022.112981_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0021-8782.2004.00325.x","article-title":"Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo","volume":"205","author":"Begbie","year":"2004","journal-title":"J. Anat."},{"key":"10.1016\/j.biopha.2022.112981_bib22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fncel.2018.00058","article-title":"Cannabinoid receptor type 1 expression in the developing avian retina: morphological and functional correlation with the dopaminergic system","volume":"12","author":"da Silva Sampaio","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166827","article-title":"Modulation of type-1 and type-2 cannabinoid receptors by saffron in a rat model of retinal neurodegeneration","volume":"11","author":"Maccarone","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112981_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.15932","article-title":"Endocannabinoid signaling enhances visual responses through modulation of intracellular chloride levels in retinal ganglion cells","volume":"5","author":"Miraucourt","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2022.112981_bib25","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1007\/s12035-019-1603-5","article-title":"The endocannabinoid system is present in rod outer segments from retina and is modulated by light","volume":"56","author":"Aguirre","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2022.112981_bib26","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1167\/iovs.07-1537","article-title":"N-arachidonylethanolamide-induced increase in aqueous humor outflow facility","volume":"49","author":"Njie","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1023\/A:1011058411804","article-title":"Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits","volume":"18","author":"Laine","year":"2001","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2022.112981_bib28","first-page":"393","article-title":"Effect of the enzyme inhibitor, phenylmethylsulfonyl fluoride, on the IOP profiles of topical anandamides","volume":"43","author":"Laine","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2008.05.003","article-title":"Aqueous humor outflow effects of 2-arachidonylglycerol","volume":"87","author":"Njie","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib30","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1167\/iovs.16-19356","article-title":"Harnessing the endocannabinoid 2-arachidonoylglycerol to lower intraocular pressure in a murine model","volume":"57","author":"Miller","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib31","first-page":"3216","article-title":"Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid","volume":"43","author":"Laine","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)35269-3","article-title":"Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2","volume":"292","author":"Song","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/jop.2007.0074","article-title":"Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor-mediated mechanism of action","volume":"24","author":"Oltmanns","year":"2008","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.exer.2005.09.017","article-title":"Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects","volume":"82","author":"Hosseini","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archopht.121.1.87","article-title":"Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys","volume":"121","author":"Chien","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ph11020050","article-title":"Controlled-deactivation CB1 receptor ligands as a novel strategy to lower intraocular pressure","volume":"11","author":"Miller","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2022.112981_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/02713680802419724","article-title":"Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbits","volume":"33","author":"Samudre","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib38","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1124\/jpet.111.185769","article-title":"Indirect sympatholytic actions at beta-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonists","volume":"339","author":"Hudson","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1476-5381.2010.00681.x","article-title":"Physical and functional interaction between CB1 cannabinoid receptors and beta2-adrenoceptors","volume":"160","author":"Hudson","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/jop.2017.0037","article-title":"The in vivo effects of the CB1-positive allosteric modulator GAT229 on intraocular pressure in ocular normotensive and hypertensive mice","volume":"33","author":"Cairns","year":"2017","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108241","article-title":"Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms","volume":"200","author":"Miller","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib42","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1167\/iovs.18-24838","article-title":"Delta(9)-tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure","volume":"59","author":"Miller","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2460\/ajvr.74.2.275","article-title":"Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs","volume":"74","author":"Fischer","year":"2013","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.biopha.2022.112981_bib44","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1167\/iovs.16-20757","article-title":"Development of a delta9-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability","volume":"58","author":"Adelli","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/tvst.8.5.15","article-title":"Delta(9)-tetrahydrocannabinol derivative-loaded nanoformulation lowers intraocular pressure in normotensive rabbits","volume":"8","author":"Taskar","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.biopha.2022.112981_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/jop.2006.22.160","article-title":"Ocular hypotensive effects of an intratracheally delivered liposomal delta9-tetrahydrocannabinol preparation in rats","volume":"22","author":"Szczesniak","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib47","doi-asserted-by":"crossref","first-page":"1253245","DOI":"10.1155\/2016\/1253245","article-title":"Cannabinoid receptors CB1 and CB2 modulate the electroretinographic waves in vervet monkeys","volume":"2016","author":"Bouskila","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.biopha.2022.112981_bib48","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1167\/iovs.13-12514","article-title":"Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice","volume":"54","author":"Cecyre","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exer.2013.02.009","article-title":"Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat","volume":"110","author":"Pinar-Sueiro","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib50","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1167\/iovs.06-1355","article-title":"Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats","volume":"48","author":"Nucci","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuropharm.2013.04.018","article-title":"The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy","volume":"72","author":"Slusar","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2022.112981_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.exer.2015.05.007","article-title":"Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: involvement of PI3K\/Akt and MEK\/ERK signaling pathways","volume":"136","author":"Kokona","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108450","article-title":"The endocannabinoid 2-arachidonoylglycerol and dual ABHD6\/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity","volume":"185","author":"Kokona","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2022.112981_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000099240","article-title":"and Intraocular pressure-lowering effects of (-)Delta 9-tetrahydrocannabinol in a rat model of glaucoma","volume":"39","author":"Crandall","year":"2007","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.biopha.2022.112981_bib55","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)63558-4","article-title":"Neuroprotective effect of(\u2212)\u03b49-tetrahydrocannabinol and cannabidiol in n-methyl-d-aspartate-induced retinal neurotoxicity","volume":"163","author":"El-Remessy","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2022.112981_bib56","first-page":"1348","article-title":"Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells","volume":"13","author":"He","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2022.112981_bib57","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1167\/iovs.04-0651","article-title":"CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility","volume":"46","author":"Zhong","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S0952523800171093","article-title":"Expression of CB2 cannabinoid receptor mRNA in adult rat retina","volume":"17","author":"Lu","year":"2000","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib59","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1046\/j.1460-9568.2000.01027.x","article-title":"The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein","volume":"12","author":"Porcella","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/syn.20856","article-title":"Distribution of CB2 cannabinoid receptor in adult rat retina","volume":"65","author":"Lopez","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.biopha.2022.112981_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuropharm.2018.08.007","article-title":"Revisiting cannabinoid receptor 2 expression and function in murine retina","volume":"141","author":"Borowska-Fielding","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2022.112981_bib62","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cne.23333","article-title":"Muller cells express the cannabinoid CB2 receptor in the vervet monkey retina","volume":"521","author":"Bouskila","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2022.112981_bib63","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1167\/iovs.11-9294","article-title":"Effects of palmitoylethanolamide on aqueous humor outflow","volume":"53","author":"Kumar","year":"2012","journal-title":"Investig Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib64","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0024-3205(02)02339-1","article-title":"Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits","volume":"72","author":"Laine","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib65","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1038\/s41598-020-72553-y","article-title":"Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2","volume":"10","author":"Cecyre","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112981_bib66","first-page":"749","article-title":"Astrocytes in the optic nerve head express putative mechanosensitive channels","volume":"21","author":"Choi","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.biopha.2022.112981_bib67","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1017\/S095252380707054X","article-title":"Vanilloid receptor 1 (TRPV1\/VR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells","volume":"24","author":"Zimov","year":"2007","journal-title":"Vis. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fncel.2018.00353","article-title":"Polymodal TRPV1 and TRPV4 sensors colocalize but do not functionally interact in a subpopulation of mouse retinal ganglion cells","volume":"12","author":"Lakk","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijdevneu.2009.07.003","article-title":"Ontogenetic expression of the vanilloid receptors TRPV1 and TRPV2 in the rat retina","volume":"27","author":"Leonelli","year":"2009","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib70","first-page":"1507","article-title":"Differential expression and localization of transient receptor potential vanilloid 1 in rabbit and human eyes","volume":"28","author":"Martinez-Garcia","year":"2013","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2022.112981_bib71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cne.20144","article-title":"Vanilloid receptor like 1 (VRL1) immunoreactivity in mammalian retina: colocalization with somatostatin and purinergic P2X1 receptors","volume":"474","author":"Yazulla","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.biopha.2022.112981_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68937-9","article-title":"Transient receptor potential vanilloid type 1 is expressed in the horizontal pathway of the vervet monkey retina","volume":"10","author":"Bouskila","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112981_bib73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1023\/B:NEUR.0000046574.72380.e8","article-title":"Localization of vanilloid receptor 1 (TRPV1\/VR1)-like immunoreactivity in goldfish and zebrafish retinas: restriction to photoreceptor synaptic ribbons","volume":"33","author":"Zimov","year":"2004","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.biopha.2022.112981_bib74","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1113\/JP274562","article-title":"Mouse retinal ganglion cell signalling is dynamically modulated through parallel anterograde activation of cannabinoid and vanilloid pathways","volume":"595","author":"Jo","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.biopha.2022.112981_bib75","doi-asserted-by":"crossref","first-page":"15369","DOI":"10.1523\/JNEUROSCI.3424-14.2014","article-title":"Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation","volume":"34","author":"Weitlauf","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib76","article-title":"Upregulation of TRPV1 signaling boosts RGC excitation early in a mouse model of glaucoma","volume":"54","author":"Weitlauf","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib77","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/19336950.2015.1009272","article-title":"Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress","volume":"9","author":"Sappington","year":"2015","journal-title":"Channels"},{"key":"10.1016\/j.biopha.2022.112981_bib78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1167\/iovs.08-2321","article-title":"TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure","volume":"50","author":"Sappington","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib79","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1523\/JNEUROSCI.4089-13.2014","article-title":"Absence of transient receptor potential vanilloid-1 accelerates stress-induced axonopathy in the optic projection","volume":"34","author":"Ward","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib80","article-title":"Absence of TRPV1 alters retinal ganglion cell compensation during glaucomatous stress","volume":"60","author":"McGrady","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib81","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10571-012-9904-5","article-title":"Retinal cell death induced by TRPV1 activation involves NMDA signaling and upregulation of nitric oxide synthases","volume":"33","author":"Leonelli","year":"2013","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2022.112981_bib82","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.exer.2010.08.026","article-title":"TRPV1 receptors are involved in protein nitration and Muller cell reaction in the acutely axotomized rat retina","volume":"91","author":"Leonelli","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2014.03.035","article-title":"Activation of the TRPV1 channel attenuates N-methyl-D-aspartic acid-induced neuronal injury in the rat retina","volume":"733","author":"Sakamoto","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib84","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jama.1971.03190100074024","article-title":"Marihuana smoking and intraocular pressure","volume":"217","author":"Hepler","year":"1971","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2022.112981_bib85","first-page":"2184","article-title":"Efferent and afferent innervation of primate trabecular meshwork and scleral spur","volume":"41","author":"Selbach","year":"2000","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib86","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1096\/fj.15-272526","article-title":"The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature","volume":"29","author":"Alawi","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.112981_bib87","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.96.25.14565","article-title":"Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system","volume":"96","author":"Straiker","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112981_bib88","article-title":"Nonretrograde endocannabinoid signalling modulates retinal ganglion cell calcium homeostasis through the TRPV1 cation channel","volume":"55","author":"Jo","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00210-013-0930-8","article-title":"Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina","volume":"387","author":"Cecyre","year":"2014","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib90","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/02713689508995801","article-title":"Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits","volume":"14","author":"Pate","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archopht.121.1.87","article-title":"Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys","volume":"121","author":"Chien","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib92","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1167\/iovs.16-21330","article-title":"A GPR119 signaling system in the murine eye regulates intraocular pressure in a sex-dependent manner","volume":"58","author":"Miller","year":"2017","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib93","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1167\/iovs.16-19437","article-title":"Evidence for a GPR18 role in diurnal regulation of intraocular pressure","volume":"57","author":"Miller","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib94","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12944-017-0586-3","article-title":"Polyunsaturated fatty acids: any role in rheumatoid arthritis?","volume":"16","author":"Navarini","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2022.112981_bib95","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/jop.2013.0179","article-title":"Effects of prostaglandin analogues on aqueous humor outflow pathways","volume":"30","author":"Winkler","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2022.112981_bib96","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2022.112981_bib97","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123978","article-title":"Cannabinoids in glaucoma patients: the never-ending story","volume":"9","author":"Passani","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2022.112981_bib98","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.survophthal.2020.07.002","article-title":"Cannabinoids and the eye","volume":"66","author":"Wang","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib99","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-4835(77)90260-3","article-title":"Cannabinoid penetration and chronic effects in the eye","volume":"24","author":"Green","year":"1977","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2022.112981_bib100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archopht.1982.01030030267006","article-title":"Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man","volume":"100","author":"Green","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib101","article-title":"Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence","volume":"146","author":"Scuteri","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112981_bib102","series-title":"Terminology and Guidelines for Glaucoma","author":"European Glaucoma Society","year":"2021"},{"key":"10.1016\/j.biopha.2022.112981_bib103","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0953-816X.2000.01401.x","article-title":"The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies","volume":"13","author":"Porcella","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib104","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2022.112981_bib106","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1167\/iovs.07-1355","article-title":"Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure","volume":"49","author":"Sappington","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib107","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/bph.12545","article-title":"Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis","volume":"171","author":"Toguri","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112981_bib108","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prostaglandins.2018.09.004","article-title":"Inflammation and CB2 signaling drive novel changes in the ocular lipidome and regulate immune cell activity in the eye","volume":"139","author":"Toguri","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.biopha.2022.112981_bib109","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/glia.22380","article-title":"Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation","volume":"60","author":"Krishnan","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2022.112981_bib110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICU.0000000000000125","article-title":"Glial cell interactions and glaucoma","volume":"26","author":"Chong","year":"2015","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.biopha.2022.112981_bib111","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fnins.2017.00318","article-title":"Interleukin-6 deficiency attenuates retinal ganglion cell axonopathy and glaucoma-related vision loss","volume":"11","author":"Echevarria","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, a widely used inhibitor of tumor necrosis factor-alpha (TNF-alpha), prevents retinal ganglion cell loss in a rat model of glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112981_bib113","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/glia.22854","article-title":"Activation of mitochondrial transient receptor potential vanilloid 1 channel contributes to microglial migration","volume":"63","author":"Miyake","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2022.112981_bib114","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB(1) receptors regulate neuronal energy metabolism","volume":"15","author":"Benard","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2022.112981_bib115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112981_bib116","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainresbull.2020.03.014","article-title":"Age-dependent alteration in mitochondrial dynamics and autophagy in hippocampal neuron of cannabinoid CB1 receptor-deficient mice","volume":"160","author":"Kataoka","year":"2020","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.biopha.2022.112981_bib117","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41419-018-1044-5","article-title":"Rapamycin and fasting sustain autophagy response activated by ischemia\/reperfusion injury and promote retinal ganglion cell survival","volume":"9","author":"Russo","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.112981_bib118","doi-asserted-by":"crossref","first-page":"PL381","DOI":"10.1016\/S0024-3205(98)00528-1","article-title":"Hydroxypropyl-beta-cyclodextrin and its combination with hydroxypropyl-methylcellulose increases aqueous solubility of delta9-tetrahydrocannabinol","volume":"63","author":"Jarho","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112981_bib119","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1208\/s12249-008-9136-7","article-title":"Preformulation studies of a prodrug of Delta9-tetrahydrocannabinol","volume":"9","author":"Thumma","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2022.112981_bib120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/acs.jmedchem.9b01142","article-title":"Application of fluorine- and nitrogen-walk approaches: defining the structural and functional diversity of 2-phenylindole class of cannabinoid 1 receptor positive allosteric modulators","volume":"63","author":"Garai","year":"2020","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2022.112981_bib121","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1021\/acs.jmedchem.1c00040","article-title":"Discovery of a biased allosteric modulator for cannabinoid 1 receptor: preclinical anti-glaucoma efficacy","volume":"64","author":"Garai","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2022.112981_bib122","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/can.2015.0005","article-title":"Allosteric modulators of the CB1 cannabinoid receptor: a structural update review","volume":"1","author":"Morales","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.biopha.2022.112981_bib123","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13543776.2016.1193157","article-title":"Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update","volume":"26","author":"Morales","year":"2016","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:25:52Z","timestamp":1780485952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":123,"alternative-id":["S0753332222003705"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112981","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112981"}}